NFKB1 and inflammatory bowel disease: The overactivation of Birc3 may be associated with chronic inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease, as it can continuously activate the NF-kB signaling pathway, leading to sustained inflammation [50].